IN RE LIPITOR (ATORVASTATIN CALCIUM) MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION

MDL No. 2502.

IN RE: LIPITOR (ATORVASTATIN CALCIUM) MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION (NO. II)

United States Judicial Panel on Multidistrict Litigation.

June 6, 2014.


Attorney(s) appearing for the Case

Annette Peters, Plaintiff, represented by Casey Aron Kaufman , The Brandi Law Firm & Thomas J. Brandi , The Brandi Law Firm.

Pfizer Inc., Defendant, represented by Karin A. Kramer , Quinn Emanuel Urquhart & Sullivan, LLP.

McKesson Corporation, Defendant, represented by Emma Elizabeth Garrison , Wheeler Trigg O'Donnell LLP.

Before: Marjorie O. Rendell, Lewis A. Kaplan, Ellen Segal Huvelle, Charles R. Breyer, Sarah S. Vance, R. David Proctor.


TRANSFER ORDER

JOHN G. HEYBURN, II, Chairman.

Before the Panel: Pursuant to Panel Rule 7.1, plaintiffs in 81 actions move to vacate our orders conditionally transferring the actions to the District of South Carolina for inclusion in MDL No. 2502. Defendants Pfizer Inc. and McKesson Corporation oppose the motions. The actions, which are listed on the attached Schedule A, are pending in the Central District of California (76 actions), the Eastern...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases